Skip to content

The effect of mite allergen avoidance by the use of allergen impermeable bedding, on asthma control in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27958413
Enrollment
1800
Registered
2004-01-23
Start date
1998-05-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory tract diseases: Asthma Respiratory Asthma

Interventions

Asthmatic patients are randomly allocated to receive either active allergen-proof covers for mattress, duvet and pillows, or a set of dummy covers which look and feel similar to the allergen-proof cov

Sponsors

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1800 asthmatics ages 18-50 years at recruitment

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Average morning peak expiratory flow rate in the four week period prior to the six month visit 2. Complete withdrawal from steroids in second six months

Secondary

MeasureTime frame
1. Use of beta agonist rescue medication and median symptom score in the four week period prior to the six month visit 2. Number of exacerbations in the six month period 3. Quality of life (St George's Respiratory Questionnaire and Short Form 36) at six month and twelve months 4. Cost of treatment and time off work (Health Care Questionnaire) 5. Change in dose of inhaled steroid in second six months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026